All adult patient populations: those without a history of cardiovascular events, and those with.
Baseline risk is something like ~35% for men, and ~20% women. Time point is from 50 to 75 years of age.
Statins -- at most -- reduce your absolute risk from 35% to 33% (for men) and from 20% to 18% (for women).
If you do not smoke, your absolute risk drops by ~7%, from 35% to 28%. If you're diabetic, your risk jumps an absolute ~30% to 65%.
See: https://www.ahajournals.org/doi/full/10.1161/circulationaha.... (table 2 & table 3).
---
Your article has this caveat: "Virtually all of the major statin studies were paid for and conducted by their respective pharmaceutical company. A long history of misrepresentation of data and occasionally fraudulent reporting of data suggests that these results are often much more optimistic than subsequent data produced by researchers and parties that do not have a financial stake in the results."
Ignoring that, 2% (absolute) of the population on statins develop diabetes and 10% (absolute) develop muscle pain/rhabdo (in one experiment). This is also ignoring all of the serious adverse events from gen-1 and gen-2 statins.
As a whole, they on average achieve a 1.2% reduction in absolute mortality (all-cause or only from heart disease?).
While I have just read it, I'm going to discount [1], because of what's inside "Declaration of interests."
And on principle, I'm not going to read [2], unless you quote the relevant sections (as is good form when referencing).